# CE Mark Study for the Harpoon Medical Device in Poland

> **NCT02432196** · NA · COMPLETED · sponsor: **Edwards Lifesciences** · enrollment: 26 (actual)

## Conditions studied

- Mitral Valve Regurgitation
- Mitral Valve Prolapse
- Mitral Valve Insufficiency

## Interventions

- **DEVICE:** Harpoon Medical Device

## Key facts

- **NCT ID:** NCT02432196
- **Lead sponsor:** Edwards Lifesciences
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12-11
- **Primary completion:** 2018-02-08
- **Final completion:** 2022-11-16
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2024-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02432196

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02432196, "CE Mark Study for the Harpoon Medical Device in Poland". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT02432196. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*